Skip to main content

Table 1 Participant demographics and clinical characteristics

From: Optimising medication management in children and young people with ADHD using a computerised test (QbTest): a feasibility randomised controlled trial

 

Intervention (n = 21)

Control (n = 23)

Mean (SD) age in years when entered the study

9.29 (2.81)

9.22 (2.19)

 

n (%)

n (%)

Gender

Male

20 (95.24)

19 (82.61)

Female

1 (4.76)

4 (17.93)

Ethnicity

Bangladeshi

1 (4.76)

0

Dual heritage

1 (4.76)

0

Not given

1 (4.76)

0

Other

1 (4.76)

1 (4.35)

Pakistani

1 (4.76)

1 (4.35)

White

16 (76.19)

21 (91.30)

ADHD diagnosis

ADHD combined subtype

18 (85.71)

14 (60.87)

ADHD—hyperactive-impulsive

2 (9.52)

5 (21.75)

ADHD—inattentive

1 (4.76)

2 (8.70)

Dual diagnosis ASD

0

1 (4.35)

Other clinical diagnoses

ASD/social communication/speech difficulties

3 (14.28)

5 (21.75)

Attachment disorder

0

1 (4.35)

Conduct disorder

0

2 (8.70)

Tic and neurological disorders

2 (9.52)

0

Mood disorders

1 (4.76)

0

  1. Data presented as n (%) unless otherwise specified. ADHD Attention deficit hyperactivity disorder, ASD Autism spectrum disorder